Immunetech Pharmaceuticals

Other

Galleon Labs LLC

Cosmederm Technologies

Cosmederm Bioscience, Inc.

Dura Pharmaceuticals, Inc.

Immunetech, Inc.

Evofem, Inc.

Cosmederm, Inc.

Gary S Hahn

David O Thueson

David R Williams

Siva Gudi

Wendell Guthrie

Timothy W Quick

Therapeutically-active compositions and formulations for treating pain, pruritus, irritation, inflammation, and tissue damage due to the irritation and inflammation, and therapeutically-active compositions and formulations for wound management, including wounds that are at high risk for infection. Strontium and beta hydroxybutyrate based compositions and formulations which can be topically applied.

Strontium based compositions and formulations for pain, pruritus, and inflammation

Therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations perform two important functions; (1) they increase the ability of topically-applied strontium to inhibit both acute sensory irritation (e.g., pruritus and pain), redness, swelling and inflammation (collectively defined for purposes of this description, 'irritation') and the chronic irritation that is characteristic of and contributes to the development and maintenance of painful or pruritic neuropathic conditions; and (2) they decrease the strontium activated pathways that are known to enhance the development and maintenance of pain, pruritis and neuropathic conditions.

Topically administered strontium-containing complexes for treating pain, pruritis and inflammation

The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using an alginic acid-based antimicrobial compound. Such compositions provide dual protection by (1) attacking and inactivating viruses and other microbes and (2) blocking the host response that viruses trigger to invade host cells. Such compositions can also be part of an acid buffering contraceptive.

Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound

Strontium-containing complexes for treatment of pain, pruritis and inflammation

The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations described herein perform two important functions; (1) they increase the ability of topically-applied strontium to inhibit both acute sensory irritation (e.g., pruritus and pain), redness, swelling and inflammation (collectively defined for purposes of this description, 'irritation') and the chronic irritation that is characteristic of and contributes to the development and maintenance of painful or pruritic neuropathic conditions; and (2) they decrease the strontium activated pathways that are known to enhance the development and maintenance of pain, pruritis and neuropathic conditions.

Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle, and methods of using these formulations to inhibit skin irritation in keratinized skin, are disclosed.

Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin

Methods for inhibiting sensory responses in the skin such as pain and itch using topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle are disclosed.

Methods for inhibiting sensory responses in the skin such as pain and itch using topical product formulations containing strontium

Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical formulation vehicle, and methods of using these formulations to inhibit skin irritation, are disclosed.

Topical product formulations containing strontium for reducing skin irritation

The present invention has a shaft with a chisel and a ladle at opposed ends. Two stops are welded to the shaft, and a slide assembly is located between the stops. A first handle is between the chisel and the first stop, and a second handle is between the ladle and the second stop. The slide assembly strikes the first stop to make the chisel break through the ice. The ladle is used to scoop out any pieces of ice that are in the hole. A rubber material is on the slide assembly and on the second handle to prevent the user's gloves from freezing thereon. The chisel can be driven into the frozen surface, but not through the frozen surface, to form an anchor. Removal of the anchor is accomplished by striking the slide assembly against the second stop.

Ice tool

Compositions and methods are provided for inhibiting skin irritations attributable to chemical irritants or environmental conditions by the application of anti-irritant amounts of aqueous soluble divalent tin cation.

Growing community of inventors

Cardiff by the Sea, CA, United States of America

Gary S Hahn